Stories & Features
Through a proteomics approach, researchers can identify more proteins and how they influence and cause diseases—providing a more holistic view to detect and treat diseases and yielding exciting developments in treating patients more effectively.
A biomarker is a biological molecule found in blood, body fluids, or tissues that is a sign of a normal or abnormal process, or of a condition or disease. Biomarkers are used to design and develop more effective therapeutics—the treatment of a particular disease.
With Proteomics, researchers can have access to more biomarkers and discover key biomarkers that relate to diseases. Biomarkers are critical in cancer research because each person's cancer has a unique pattern of biomarkers, and some biomarkers affect how cancer treatments work making it difficult to find the right treatment. Biomarker testing with Proteomics can help doctors choose a treatment that is more effective for an individual patient.
Cancer researchers have already attempted to use proteomics for diagnostic and prognostic purposes. These efforts led to new diagnostics that will provide a new method of diagnosis and disease identification for ovarian cancer.
IDEX Health & Science can develop fluidic instruments for OEMs that can be used in Proteomic research for Liquid Chromatography, Mass Spectrometry, Flow Cytometry, Spatial Biology, and Multiplexing.
The time to partner with IDEX Health & Science on your Proteomics plan is now. The possibilities are limitless, and the investment will help improve lives for generations to come.
Learn More About Our OEM Capabilities Within The Proteomics Space